Caliway Biopharmaceuticals (TWSE: 6919), a clinical-stage biopharmaceutical company advancing innovative small-molecule therapies for aesthetic medicine and metabolic diseases, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results